Seladelpar

Chemical formula: C₂₁H₂₃F₃O₅S  Molecular mass: 444.122 g/mol  PubChem compound: 11236126

Therapeutic indications

Seladelpar is indicated for:

Primary biliary cholangitis (PBC)

Population group: only adults (18 years old or older)

Seladelpar is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA alone, or as monotherapy in those unable to tolerate UDCA.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Seladelpar is contraindicated in the following cases:

Lactation

Lactation

Biliary obstruction

Obstruction of biliary tree

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2026: LYVDELZI Hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈